DHW-221, a Dual PI3K/mTOR Inhibitor, Overcomes Multidrug Resistance by Targeting P-Glycoprotein (P-gp/ABCB1) and Akt-Mediated FOXO3a Nuclear Translocation in Non-small Cell Lung Cancer

Multidrug resistance (MDR) is considered as a primary hindrance for paclitaxel failure in non-small cell lung cancer (NSCLC) patients, in which P-glycoprotein (P-gp) is overexpressed and the PI3K/Akt signaling pathway is dysregulated. Previously, we designed and synthesized DHW-221, a dual PI3K/mTOR...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Mingyue Liu, Chang Xu, Xiaochun Qin, Wenwu Liu, Deping Li, Hui Jia, Xudong Gao, Yuting Wu, Qiong Wu, Xiangbo Xu, Bo Xing, Xiaowen Jiang, Hongyuan Lu, Yingshi Zhang, Huaiwei Ding, Qingchun Zhao
格式: Artigo
語言:Inglês
出版: Frontiers Media S.A. 2022-05-01
叢編:Frontiers in Oncology
主題:
NSCLC
P-glycoprotein
FOXO3a nuclear translocation
Multidrug resistance
DHW-221
paraptosis
在線閱讀:https://www.frontiersin.org/articles/10.3389/fonc.2022.873649/full
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍